Description
GLP-1T (Tirz) is described as a single molecule that activates both GIP and GLP-1 receptors in the body. This dual-agonist profile has made this a major focus of metabolic and incretin-pathway research. Its once-weekly design and combined receptor activity have helped distinguish it from products that target only one incretin pathway. For product description use, it can be positioned as an advanced dual-pathway GLP-1/GIP research compound.
Reviews
There are no reviews yet.